Form D · Biotechnology

Foundation Medicine, Inc.

Cambridge, MA · CIK 0001488613

Offering snapshot reported Jan 10, 2013 · SEC filing

Reported sold
$56M
Offering amount: $56M
Investors reported
22
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 10, 2012
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$28M$56MSep 21, 2012: $42,499,987.00Sep 21, 2012Jan 10, 2013: $55,962,423.00Jan 10, 2013

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$42,499,987 → $55,962,423
  • Reported investors19 → 22

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 10, 2013Amendment$55,962,423$13,462,436vs Sep 21, 201222SEC filing
Sep 21, 2012Initial$42,499,987No comparison19SEC filing
Aug 23, 2011Initial$10,000,000No comparison1SEC filing
Apr 15, 2010Initial$7,000,000No comparison1SEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0 (estimated)
Finders' fees
$0 (estimated)
Form D file number
021-184482

Source: Form D, filed Jan 10, 2013. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Alexis Borisy Director
Alexis Borisy, M.S. Director
Brook Byers Director
Robert W. Hesslein Executive
Evan Jones Director
Kevin Krenitsky Executive
Kevin Krenitsky, M.D. Executive
Mark Levin Director
Michael J. Pellini Director, Executive
Michael Pellini, M.D. Director, Executive
Jason Ryan Executive
David Schenkein Director
Robert Tepper Director
Robert Tepper, M.D. Director
Krishna Yeshwant Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
One Kendall Square Suite B3501
Cambridge, MA, 02139